RLIM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.524800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.625400E-01
Normal-vs-Stage2
9.704800E-01
Normal-vs-Stage3
1.902620E-01
Normal-vs-Stage4
1.491810E-01
Stage1-vs-Stage2
4.641800E-01
Stage1-vs-Stage3
1.237600E-02
Stage1-vs-Stage4
1.041970E-01
Stage2-vs-Stage3
1.628200E-01
Stage2-vs-Stage4
2.140200E-02
Stage3-vs-Stage4
1.476410E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.590800E-01
Normal-vs-AfricanAmerican
6.980600E-01
Normal-vs-Asian
6.476400E-01
Caucasian-vs-AfricanAmerican
4.900200E-01
Caucasian-vs-Asian
3.181600E-01
AfricanAmerican-vs-Asian
2.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.659000E-01
Normal-vs-Female
8.381400E-01
Male-vs-Female
3.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.520200E-01
Normal-vs-Age(41-60Yrs)
5.010000E-01
Normal-vs-Age(61-80Yrs)
8.069800E-01
Normal-vs-Age(81-100Yrs)
3.835000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.137000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.484600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.483600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.433300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.482520E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.579400E-01
Normal-vs-Daily Drinker
7.211600E-01
Normal-vs-Weekly Drinker
7.792200E-01
Normal-vs-Occasional Drinker
4.815200E-01
Normal-vs-Social Drinker
7.030400E-01
Non Drinker-vs-Daily Drinker
6.983800E-01
Non Drinker-vs-Weekly Drinker
6.298600E-01
Non Drinker-vs-Occasional Drinker
8.301300E-03
Non Drinker-vs-Social Drinker
6.790100E-02
Daily Drinker-vs-Weekly Drinker
8.999600E-01
Daily Drinker-vs-Occasional Drinker
3.701700E-02
Daily Drinker-vs-Social Drinker
1.730050E-01
Weekly Drinker-vs-Occasional Drinker
8.764300E-02
Weekly Drinker-vs-Social Drinker
2.748800E-01
Occasional Drinker-vs-Social Drinker
5.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.869400E-01
Normal-vs-Grade 2
9.384400E-02
Normal-vs-Grade 3
7.187800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.449200E-01
Grade 1-vs-Grade 3
4.198800E-01
Grade 1-vs-Grade 4
2.869400E-01
Grade 2-vs-Grade 3
7.803400E-01
Grade 2-vs-Grade 4
9.384400E-02
Grade 3-vs-Grade 4
7.187800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.825200E-01
Normal-vs-NonDiabetic
9.807400E-01
Diabetic-vs-NonDiabetic
2.194400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.840400E-01
Normal-vs-NoPancreatitis
9.931400E-01
Pancreatitis-vs-NoPancreatitis
2.725600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.970200E-01
Normal-vs-N1
9.233000E-01
N0-vs-N1
7.311000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.345200E-01
Normal-vs-TP53-NonMutant
9.767600E-01
TP53-Mutant-vs-TP53-NonMutant
2.307200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
